In the UK, NHS consultants have earned millions more than claimants over vaccine damage through the Vaccine Damage Payment Scheme. Crawford and Company received £27M, overshadowing victim payouts of £24M. Almost 13,000 cases evaluated, with over 98% rejected, causing transparency concerns. Most payouts link to AstraZeneca, demanding proof of vaccine-induced disability, now set at a 60% threshold. Critics denounce the cut-off as arbitrary, noting Crawford’s poor reputation with unfair denials. Economic strain and lack of transparency fuel public frustration and calls for reform.